In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
134 News Items found
Alexandra Joyner, Ming Li, and Kenneth Offit
Three Memorial Sloan Kettering Cancer Center Faculty Members Elected as 2021 AAAS Fellows

Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.
The outside of the David H. Koch Center for Cancer Care at MSK
In the Clinic
The Latest Interventional Radiology Targets Liver Tumors Without Surgery 

For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue. 
Jeffrey Drebin
The Crucial Need for Cancer Treatment and Screening During COVID-19

In a recent interview, MSK's Dr. Jeffrey Drebin addressed why it’s important for people to keep up with their routine screenings and not put off cancer treatment or surgery.
Ross Levine
MSK Hematologist: COVID-19 Has Impacted Every Facet of Cancer Medicine and Research

The oncology community has stepped up to meet the challenges of the ongoing COVID-19 pandemic but must redouble their efforts in order to stem the potential long-term consequences of this public health crisis on the field.
MSK medical oncologist Alexander Drilon
Feature
First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.
Investigators Lea Moukarzel, Kimberly Dessources, Britta Weigelt, and Sarah Kim in the lab.
Finding
Unique Genetic Change Found in Rare Ovarian Tumor Could Spare Patients from Unnecessary Treatment

The research focused on sclerosing stromal tumor, a rare, benign ovarian tumor that is not cancer but can be misdiagnosed as cancer.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.
A researcher working in an MSK lab
MSK Research Highlights September 18, 2024

New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
Physician-scientist Alex Kentsis
In the Lab
Research Shows How Common Feature of Blood Cancers Can Be Targeted

Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.